SKINĒDIT AGELESS 01 / 28
Aged Face
Young Face
YoungAged
← Drag to Compare →
Chapter I — The Surface Illusion
The Portrait
Illusion.

You have been told that aging is a gentle, skin-deep decline. You've been given topical creams to polish the surface. You've been sold a superficial myth.

1%
The Tip of the Iceberg

Topical skincare targets the visible 1% of surface dry lines, while the remaining 99% of structural bone and collagen matrix deterioration happens completely unaddressed beneath.

Chapter I — The Surface Illusion

The 1% Myth:
The Iceberg.

Standard skincare claims aging is a predictable, linear loss of 1% collagen per year. It is a comforting lie that ignores the biological trigger points of real facial collapse.

THE REALITY

Aging is non-linear. It is characterized by sudden, catastrophic structural shifts — cliffs — that occur deep within the facial anatomy where topicals cannot penetrate.

Chapter I — The Surface Illusion

The Post-45
Freefall.

At age 45, protective hormonal support declines. Normal physiological aging accelerates into a rapid, unanchored structural collapse — collagen drops by 30% in just five years.

Age Bracket Collagen Loss Bone Resorption
Ages 25–45 Baseline −1.0% / yr −0.3% / yr
Ages 45–55 The Cliff Phase −6.0% / yr −3.0% / yr
Ages 55+ Late Stage −2.0% / yr −1.0% / yr
Structural Cliff Visualization
Slide 04 — Target Profiles

Who is AGELESS for?

An advanced systemic protocol targeted toward the physical and chemical root causes of deep facial degradation.

Post-45 Cliff
Individuals experiencing accelerated systemic collagen collapse and bone density loss post-menopause.
Drapery Sagging
Those witnessing jawline softening, falling fat pads, and loose facial contours as skeletal anchors recede.
Deep Expressions
For static nasolabial folds and deepening lines set into place by progressive dermal elastocalcinosis.
Volume Loss & Hollows
Sunken cheeks, recessed eye sockets, and structural volume reduction caused by facial bone resorption.
Loss of Snap-back
Brittle, mineralized elastic tissues that have lost natural thickness, pliability, and rebound capacity.
Active Preemption
Ages 30+ seeking to proactively protect the bone matrix and cross-link young collagen networks.
Slide 05 — Mineral Dysregulation
The Calcium Paradox.
The Blueprint

Calcium belongs strictly inside the bone matrix to maintain skeletal density and facial lift.

The Deviation

As the body ages, calcium leaches out of the facial skeleton and migrates into the soft tissue of the skin.

The Inverse Reality

Calcium inside the bone creates volume. Calcium inside the skin rigidifies elastic fibers, locking in wrinkles.

Calcified Elastic Fiber
Chapter II — The Mineral Sabotage

Pathological
Petrification.

This is Elastocalcinosis. The migrated calcium binds directly to the elastic fibers of your dermis. Skin that should be soft and springy becomes chemically petrified, brittle, and dry.

THE RESULT

The skin completely loses its elastic rebound, permanently locking deep expression lines into place.

Chapter II — The Mineral Sabotage

In bones, a scaffold.
In skin, a stone.

Topical creams smooth the surface, but deep calcification continues. Calcium in your bones creates structural volume and lift; calcium in your skin rigidifies the elastic grid, permanently setting deep folds in place.

SKELETAL SCAFFOLD

Calcium belongs inside the bone matrix, keeping the structural platform broad and the skin taut.

DERMAL STONE

When bone resorbs, calcium migrates, petrifying the soft skin fibers into dry, unyielding rigidity.

Chapter II — The Mineral Sabotage
Enzymatic Demolition.

To make matters worse, UV rays and oxidative stress activate Matrix Metalloproteinases (MMPs) — destructive cellular "scissors" that sever the remaining dry, calcified collagen fibers.

UV & Oxidative Stress Level
NONE0%CRITICAL
SUBJECT: SK-EDIT-4587 // FEMALE
Craniofacial Resorption
98.4%
Bone Density Index
94.1%
Dermal Elasticity
Diagnostic Controls

Manipulate the biological timeline and dermal opacity to observe structural collapse.

Biological Age30 YRS
← Drag Model to Rotate →
AGX-3™ Matrix
MESOPOROSIL® The Architect
Rebuilding the Collagen Scaffold from Within
96.7% BIOAVAIL.
Human Absorbed Fraction
Ex vivo transintestinal testing confirmed
380×
More Soluble
vs standard solid silicium in water after 8h
27×
Higher Liberation
Silicium release in FaSSIF vs leading supplements
72.7% FIRMER
Firmer Skin & Hydration
84-Day Clinical Trial
68.2% ELAST.
Elasticity & Radiance
Improved skin snap-back
50% WRINKLE
Wrinkle Reduction
Significant reduction by Day 56
~73 ng/mL
Cmax in 1 Hour
Rapid plasma peak post-administration
AGX-3™ Matrix
K2VITAL® DELTA The Traffic Controller
Redirecting Calcium from Skin to Skeleton
95% ABSORB.
K2 (MK-7) Absorption
vs 5–10% for dietary Vitamin K1
Vitamin K1
K2VITAL® MK-7
96.9% FIRM
Restored Firmness
Calcium redirected to skeletal frame
MGP
Activates Matrix Gla Protein
The body's calcium traffic cop
NanoLift™ Complex
CERAMOSIDES® The Lipid Mortar
Sealing the Moisture Barrier & Preserving Collagen
+37%
Hydration Increase
vs placebo, in as little as 2 weeks
-19%
TEWL Reduction
Trans-Epidermal Water Loss sealed
-17%WRINKLES
Wrinkle Reduction
Within 60 days
+36%
Elasticity Improvement
Skin "snap-back" recovery
>80%ELASTASE
Elastase Inhibition
Preserves elastic fibers
+33%
TIMP-1 Increase
Stops MMP-1 from destroying collagen
Longevity Shield
ASTAXANTHIN The Biological Brake
Paralyzing the Molecular Scissors
6,000×
Stronger than Vit C
Singlet oxygen quenching power
770×
vs Coenzyme Q10
Active antioxidant comparison
100×
vs Vitamin E
Potency in oxidative defense
6.5h
11.5h
Tmax Range
Time to max plasma level (10–100mg)
21h
Elimination Half-Life
Long-lasting systemic presence
6mg
8-Week Clinical Dose
Improved crow's feet, age spots, moisture
Longevity Shield
L-ERGOTHIONEINE The DNA Guardian
Clinical Anti-Aging Evidence (28-Day Trial)
-22.6% AREA
Wrinkle Area Reduction
Total wrinkle surface in 4 weeks
-29.2% CARB.
Carbonylation Reduction
Permanent UV-induced oxidative damage marker
+21.6%
Smoothness Improvement
Facial parameter scores increase
+9.7%
Moisture Increase
With -11.9% TEWL reduction
+6.4%
Elasticity (R2)
Improved skin firmness parameter
Longevity Shield
LUTEIN Biological Sunglasses
Internal Light Filtration & Systemic Defense
89% PROB.
Skin Radiance
Top-tier radiance scores likelihood
91% PROB.
Texture Improvement
Likelihood of significant smoothing
BLUE LIGHT
Systemic Filter
Filters high-energy UV radiation
CASCADE
Photo-Oxidative Block
Quenches Singlet Oxygen at cellular level
Part II — The SKINĒDIT Intervention
AGX-3™:
Rebuild & Redirect.
AGX-3™
COMPLEX
K2VITAL®
DELTA
Mesoporosil®
Vitamin D3
Transitional Asset
The Cross-Linking Cascade.

Observe the molecular choreography of collagen thread binding under NanoLift™ enzymatic activation.

Slide 18 — Dermal Architecture
NANOLIFT™:
Reinforce & Cross-Link.
NANOLIFT™
COMPLEX
Copper
Bisglycinate
Ceramosides®
Zinc &
Vitamin C
Slide 19 — Cellular Defense
The Longevity
Shield.
Astaxanthin 60mg
6,000× more potent than Vitamin C. Paralyzes MMP enzymes.
Lutein
Filters harmful UV and blue light at the cellular level.
Mitochondrial ATP Battery
CoQ10 & Alpha-Lipoic Acid trigger mitochondrial biogenesis.
Activate AGELESS Shield
The Longevity Switch
Activating the
"Longevity Gene"
🔑
The Target: FOXO-3
Forkhead box O3 — The body's master switch for cellular lifespan and quality control.
The Dual-Action Trigger
L-Ergothioneine: Acts on Sirtuins (SIRT1) to unlock FOXO-3.
The Longevity Shield: Maintains mitochondrial integrity & activates Nrf2.
🛡️
The Three Survival Commands
1. Cleaning: Triggers Autophagy to purge toxic build-up.
2. Genetic Armor: Repairs DNA strand breaks.
3. Universal Defense: Surges SOD & Glutathione.
Slide 21 — Complete Protocol
AGELESS: The Complete Protocol.
Skeletal Engine / AGX-3™
K2VITAL® DELTA Patented
Redirects calcium from skin back to bone.
Mesoporosil® Patented
Stimulates osteoblast differentiation.
Vitamin D3
Locks calcium into bone matrix.
Dermal Engine / NANOLIFT™
Copper Bisglycinate Chelated
Cross-links collagen into firm mesh.
Ceramosides® Patented
Restores lipid mortar. Reduces TEWL.
Zinc Bisglycinate Chelated
Essential for collagen formation.
Longevity Shield
Astaxanthin (60mg)
Paralyzes MMP activity.
CoQ10 & L-Ergothioneine
Mitochondrial biogenesis & DNA protection.
Lutein & ALA
Internal UV filter & universal antioxidant.
Part III — Clinical Proof
Independent Instrumental Evidence.
96.9%
Restored Firmness
Measurable increase in deep dermal tension.
-11.2%
Wrinkle Depth Reduction
Structural smoothing of deep expression anchors.
+29.4%
Deep Hydration
Instrumental confirmation of a completely sealed lipid barrier.
Clinical
Cutometer — Firmness & Elasticity
Clinical
Visioscan — Wrinkle Depth & Texture
Clinical Trial Dashboard
33 Women90 Days
-0%
Structural Redensification
+0%
Dermal Matrix Saturation
Firmness
0%
Wrinkle Red.
-0%
Firmer
0%
Smoother
0%
Contours
0%
Youthful
0%
0%

62% showed measurable global improvement.

Volunteer 011 / 6
Slide 25 — Clinical Timeline
The 90-Day Protocol.
1
Days 15–30
The Hydration Phase.

Ceramosides® repair the lipid barrier.

2
Days 30–60
The Matrix Phase.

Fibroblasts utilize NanoLift™ to cross-link fresh collagen.

3
Days 60–90
The Structural Phase.

AGX-3™ re-mineralization stabilizes bone density.

Quality & Compliance
Scientific Standards of Excellence.
Made in France
Formulated and manufactured under precise laboratory conditions in Paris
GMP
GMP Certified
Manufactured in full compliance with global Good Manufacturing Practices
100% Vegan
Plant-derived matrix. Absolute purity with zero animal elements or gelatin
0%
Zero Fillers
No synthetic agents, magnesium stearate, or chemical flowing agents
CL
COMPLIFE® Vetted
Clinical trial outcomes fully vetted and certified by COMPLIFE® analytic division
Victoire de la Beauté
AGELESS is a proud winner of the prestigious French blind-test beauty jury award
Slide 27 — Scientific Evidence
The Peer-Reviewed Evidence Base.
I. Facial Skeleton & Bone Resorption

Shaw, r.B., et al. (2011). "Aging of the Facial Skeleton: Aesthetic Implications and Rejuvenation Strategies." Plastic and Reconstructive Surgery.

Mendelsohn, A.S., et al. (2012). "Age-Related Changes of the Facial Skeleton: An Anatomical and Surgical Review." Aesthetic Surgery Journal.

Shuster, S. (2005). "Osteoporosis, a unitary hypothesis of collagen loss in skin and bone." Medical Hypotheses.

Boskey, A.L. (2013). "Bone Composition: Relationship to Bone Fragility." Bonekey Reports.

II. AGX-3™ Matrix (Silicium & K2)

Mannu, N., et al. (2026). "From dissolution to dermal benefits: In vitro, ex vivo, and in vivo evaluation of mesoporosil®..." CosmoDerma.

Mohta, A., Mannu, N., et al. (2025). "Efficacy and safety of mesoporosil treatment in enhancing skin firmness..." CosmoDerma.

Siddiqui, S.S., et al. (2018). "Mesoporosil®: A Novel Silicon Delivery System with Superior Bioavailability." Journal of Medicinal Food.

Reffitt, D.M., et al. (2003). "Orthosilicic acid stimulates collagen type 1 synthesis..." Bone.

Takaishi, M., et al. (2016). "Matrix Gla Protein: A Calcium-Binding Protein..." Journal of Biological Chemistry.

Seyama, Y., et al. (2010). "Elastocalcinosis: Calcium Deposition in Elastin Fibers..." Gerodontology.

Knapen, M.H.J., et al. (2015). "Menaquinone-7 supplementation improves arterial stiffness..." Thrombosis and Haemostasis.

Simes, D.C., et al. (2019). "Vitamin K as a Powerful Micronutrient in Aging." International Journal of Molecular Sciences.

III. NanoLift™ Complex (Dermal & Lipid)

Kern, C., et al. (2024). "Dietary supplementation with a wheat polar lipid complex..." Journal of Cosmetic Dermatology.

Bizot, V., et al. (2017). "Improving skin hydration and age-related symptoms..." Cosmetics.

Camera, E., et al. (2018). "Ceramosides®: Phytoceramides for Skin Hydration..." International Journal of Cosmetic Science.

Meckfessel, M.H. & Brandt, S. (2014). "The structure, function, and importance of ceramides in skin." Journal of the American Academy of Dermatology.

IV. Longevity Shield (Antioxidant & Defense)

Davinelli, S., et al. (2018). "Astaxanthin in Skin Health, Repair, and Disease..." Nutrients.

Ito, N., et al. (2018). "The protective role of astaxanthin for UV-induced skin deterioration..." Nutrients.

Suganuma, K., et al. (2010). "Astaxanthin attenuates the UVA-induced up-regulation of matrix-metalloproteinase-1." Journal of Dermatological Science.

Tominaga, K., et al. (2012). "Cosmetic benefits of astaxanthin on human subjects." Acta Biochimica Polonica.

Bazela, K., et al. (2014). "L-Ergothioneine protects skin cells against UV-induced damage..." Cosmetics.

Cheng, D., et al. (2022). "The Effects of L-ergothioneine on Skin Hydration, Elasticity..." Current Trends on Biotechnology & Microbiology.

Hseu, Y.C., et al. (2020). "The Antiaging Activity of Ergothioneine in UVA-Irradiated Human Dermal Fibroblasts..." Oxidative Medicine and Cellular Longevity.

Cheah, I.K. & Halliwell, B. (2012). "Ergothioneine; antioxidant potential, physiological function..." Biochimica et Biophysica Acta.

Palombo, P., et al. (2007). "Beneficial long-term effects of combined oral/topical antioxidant treatment with lutein..." Skin Pharmacology and Physiology.

Juturu, V., et al. (2016). "Overall skin tone and skin-lightening-improving effects..." Clinical, Cosmetic and Investigational Dermatology.

Zmitek, K., et al. (2016). "The effect of dietary intake of coenzyme Q10 on skin parameters..." BioFactors.

Slominski, A.T., et al. (2021). "Vitamin D on Skin Aging." International Journal of Molecular Sciences.

SKINĒDIT AGELESS — The Structural Intervention
Redirect · Rebuild · Reinforce

SKINĒDIT AGELESS is a precision-engineered, multi-pathway structural intervention — clinically validated to reverse the foundational mechanisms of facial aging.